Literature DB >> 17077150

Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning.

Wen-Sung Lai1, Bin Xu, Koen G C Westphal, Marta Paterlini, Berend Olivier, Paul Pavlidis, Maria Karayiorgou, Joseph A Gogos.   

Abstract

There is accumulating evidence that AKT signaling plays a role in the pathogenesis of schizophrenia. We asked whether Akt1 deficiency in mice results in structural and functional abnormalities in prefrontal cortex (PFC). Exploratory transcriptional profiling revealed concerted alterations in the expression of PFC genes controlling synaptic function, neuronal development, myelination, and actin polymerization, and follow-up ultrastructural analysis identified consistent changes in the dendritic architecture of pyramidal neurons. Behavioral analysis indicated that Akt1-mutant mice have normal acquisition of a PFC-dependent cognitive task but abnormal working memory retention under neurochemical challenge of three distinct neurotransmitter systems. Thus, Akt1 deficiency creates a context permissive for gene-gene and gene-environment interactions that modulate PFC functioning and contribute to the disease risk associated with this locus, the severity of the clinical syndrome, or both.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17077150      PMCID: PMC1636552          DOI: 10.1073/pnas.0604994103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Selective D2 receptor actions on the functional circuitry of working memory.

Authors:  Min Wang; Susheel Vijayraghavan; Patricia S Goldman-Rakic
Journal:  Science       Date:  2004-02-06       Impact factor: 47.728

2.  The T-maze continuous alternation task for assessing the effects of putative cognition enhancers in the mouse.

Authors:  L Spowart-Manning; F J van der Staay
Journal:  Behav Brain Res       Date:  2004-05-05       Impact factor: 3.332

3.  D2 receptor regulation of synaptic burst firing in prefrontal cortical pyramidal neurons.

Authors:  Yun Wang; Patricia S Goldman-Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205

Review 4.  White matter changes in schizophrenia: evidence for myelin-related dysfunction.

Authors:  Kenneth L Davis; Daniel G Stewart; Joseph I Friedman; Monte Buchsbaum; Philip D Harvey; Patrick R Hof; Joseph Buxbaum; Vahram Haroutunian
Journal:  Arch Gen Psychiatry       Date:  2003-05

5.  Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine.

Authors:  Jenna S Franowicz; Lynn E Kessler; Catherine M Dailey Borja; Brian K Kobilka; Lee E Limbird; Amy F T Arnsten
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

6.  Control of synaptic strength, a novel function of Akt.

Authors:  Qinghua Wang; Lidong Liu; Lin Pei; William Ju; Gholamreza Ahmadian; Jie Lu; Yushan Wang; Fang Liu; Yu Tian Wang
Journal:  Neuron       Date:  2003-06-19       Impact factor: 17.173

7.  Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia.

Authors:  Effat S Emamian; Diana Hall; Morris J Birnbaum; Maria Karayiorgou; Joseph A Gogos
Journal:  Nat Genet       Date:  2004-01-25       Impact factor: 38.330

8.  Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.

Authors:  Christoph Kellendonk; Eleanor H Simpson; H Jonathan Polan; Gaël Malleret; Svetlana Vronskaya; Vanessa Winiger; Holly Moore; Eric R Kandel
Journal:  Neuron       Date:  2006-02-16       Impact factor: 17.173

9.  Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade.

Authors:  Jean-Martin Beaulieu; Tatyana D Sotnikova; Wei-Dong Yao; Lisa Kockeritz; James R Woodgett; Raul R Gainetdinov; Marc G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-24       Impact factor: 11.205

Review 10.  Physiological functions of protein kinase B/Akt.

Authors:  Z-Z Yang; O Tschopp; A Baudry; B Dümmler; D Hynx; B A Hemmings
Journal:  Biochem Soc Trans       Date:  2004-04       Impact factor: 5.407

View more
  68 in total

1.  An association study on the polymorphisms of dopaminergic genes with working memory in a healthy Chinese Han population.

Authors:  Pingyuan Gong; Hang Zhang; Wanyu Chi; Wanhua Ge; Kejin Zhang; Anyun Zheng; Xiaocai Gao; Fuchang Zhang
Journal:  Cell Mol Neurobiol       Date:  2012-02-24       Impact factor: 5.046

2.  Antipsychotic drugs activate the C. elegans akt pathway via the DAF-2 insulin/IGF-1 receptor.

Authors:  Kathrine R Weeks; Donard S Dwyer; Eric J Aamodt
Journal:  ACS Chem Neurosci       Date:  2010-03-25       Impact factor: 4.418

3.  Gene function analysis in complex data sets using ErmineJ.

Authors:  Jesse Gillis; Meeta Mistry; Paul Pavlidis
Journal:  Nat Protoc       Date:  2010-06-03       Impact factor: 13.491

Review 4.  Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.

Authors:  George Bartzokis
Journal:  Neuropharmacology       Date:  2012-01-28       Impact factor: 5.250

Review 5.  GSK-3β activity and hyperdopamine-dependent behaviors.

Authors:  Yan-Chun Li; Wen-Jun Gao
Journal:  Neurosci Biobehav Rev       Date:  2010-08-18       Impact factor: 8.989

Review 6.  Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.

Authors:  Judith Pratt; Catherine Winchester; Neil Dawson; Brian Morris
Journal:  Nat Rev Drug Discov       Date:  2012-06-22       Impact factor: 84.694

7.  The pattern of cortical dysfunction in a mouse model of a schizophrenia-related microdeletion.

Authors:  Karine Fénelon; Bin Xu; Cora S Lai; Jun Mukai; Sander Markx; Kimberly L Stark; Pei-Ken Hsu; Wen-Biao Gan; Gerald D Fischbach; Amy B MacDermott; Maria Karayiorgou; Joseph A Gogos
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

8.  DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia.

Authors:  Giuseppe Blasi; Francesco Napolitano; Gianluca Ursini; Paolo Taurisano; Raffaella Romano; Grazia Caforio; Leonardo Fazio; Barbara Gelao; Annabella Di Giorgio; Luisa Iacovelli; Lorenzo Sinibaldi; Teresa Popolizio; Alessandro Usiello; Alessandro Bertolino
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

Review 9.  Constitutional mechanisms of vulnerability and resilience to nicotine dependence.

Authors:  N Hiroi; D Scott
Journal:  Mol Psychiatry       Date:  2009-02-24       Impact factor: 15.992

10.  FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder.

Authors:  Katarzyna A Ellsworth; Irene Moon; Bruce W Eckloff; Brooke L Fridley; Gregory D Jenkins; Anthony Batzler; Joanna M Biernacka; Ryan Abo; Abra Brisbin; Yuan Ji; Scott Hebbring; Eric D Wieben; David A Mrazek; Richard M Weinshilboum; Liewei Wang
Journal:  Pharmacogenet Genomics       Date:  2013-03       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.